686 related articles for article (PubMed ID: 26158218)
1. Oncogenic cancer/testis antigens: prime candidates for immunotherapy.
Gjerstorff MF; Andersen MH; Ditzel HJ
Oncotarget; 2015 Jun; 6(18):15772-87. PubMed ID: 26158218
[TBL] [Abstract][Full Text] [Related]
2. [Targeting cancer antigen (MAGE-A4, NY-ESO -1) for immunotherapy].
Imai N; Ikeda H; Shiku H
Nihon Rinsho; 2012 Dec; 70(12):2125-9. PubMed ID: 23259384
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
4. Cancer-testis antigens: potential targets for cancer immunotherapy.
Ghafouri-Fard S; Modarressi MH
Arch Iran Med; 2009 Jul; 12(4):395-404. PubMed ID: 19566358
[TBL] [Abstract][Full Text] [Related]
5. A novel era of cancer/testis antigen in cancer immunotherapy.
Meng X; Sun X; Liu Z; He Y
Int Immunopharmacol; 2021 Sep; 98():107889. PubMed ID: 34174699
[TBL] [Abstract][Full Text] [Related]
6. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
Scanlan MJ; Gure AO; Jungbluth AA; Old LJ; Chen YT
Immunol Rev; 2002 Oct; 188():22-32. PubMed ID: 12445278
[TBL] [Abstract][Full Text] [Related]
7. Cancer/testis (CT) antigens: potential targets for immunotherapy.
Caballero OL; Chen YT
Cancer Sci; 2009 Nov; 100(11):2014-21. PubMed ID: 19719775
[TBL] [Abstract][Full Text] [Related]
8. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
10. Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors.
Leko V; Rosenberg SA
Cancer Cell; 2020 Oct; 38(4):454-472. PubMed ID: 32822573
[TBL] [Abstract][Full Text] [Related]
11. Novel tools to assist neoepitope targeting in personalized cancer immunotherapy.
Saini SK; Rekers N; Hadrup SR
Ann Oncol; 2017 Dec; 28(suppl_12):xii3-xii10. PubMed ID: 29092006
[TBL] [Abstract][Full Text] [Related]
12. Immunological and functional aspects of MAGEA3 cancer/testis antigen.
Das B; Senapati S
Adv Protein Chem Struct Biol; 2021; 125():121-147. PubMed ID: 33931137
[TBL] [Abstract][Full Text] [Related]
13. Cancer testis antigens as immunogenic and oncogenic targets in breast cancer.
Mahmoud AM
Immunotherapy; 2018 Jul; 10(9):769-778. PubMed ID: 29926750
[TBL] [Abstract][Full Text] [Related]
14. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.
Siliņa K; Zayakin P; Kalniņa Z; Ivanova L; Meistere I; Endzeliņš E; Abols A; Stengrēvics A; Leja M; Ducena K; Kozirovskis V; Linē A
J Immunother; 2011 Jan; 34(1):28-44. PubMed ID: 21150711
[TBL] [Abstract][Full Text] [Related]
15. Developments in cancer immunotherapy.
van den Broek M; von Boehmer L; Knuth A
Dig Dis; 2010; 28(1):51-6. PubMed ID: 20460890
[TBL] [Abstract][Full Text] [Related]
16. Cancer-testis antigens: targets for cancer immunotherapy.
Chen YT; Old LJ
Cancer J Sci Am; 1999; 5(1):16-7. PubMed ID: 10188055
[No Abstract] [Full Text] [Related]
17. Future approaches in immunotherapy.
Rini B
Semin Oncol; 2014 Oct; 41 Suppl 5():S30-40. PubMed ID: 25438998
[TBL] [Abstract][Full Text] [Related]
18. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy.
Gjerstorff MF; Besir H; Larsen MR; Ditzel HJ
Protein Expr Purif; 2010 Oct; 73(2):217-22. PubMed ID: 20546897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
